Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex.

Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex.
复制标题

DOI:
10.1016/j.urolonc.2017.11.021
复制
发表时间:
2017-12
期刊:
Urologic oncology
影响因子:
--
通讯作者:
David Schlütermann;M. Skowron;N. Berleth;P. Böhler;J. Deitersen;Fabian Stuhldreier;Nora Wallot-Hieke;Wenxian Wu;C. Peter;M. Hoffmann;G. Niegisch;B. Stork
David Schlütermann;M. Skowron;N. Berleth;P. Böhler;J. Deitersen;Fabian Stuhldreier;Nora Wallot-Hieke;Wenxian Wu;C. Peter;M. Hoffmann;G. Niegisch;B. Stork
中科院分区:
其他
文献类型:
--
作者:
David Schlütermann;M. Skowron;N. Berleth;P. Böhler;J. Deitersen;Fabian Stuhldreier;Nora Wallot-Hieke;Wenxian Wu;C. Peter;M. Hoffmann;G. Niegisch;B. Stork

文献摘要

相似文献